PRISM Study-Pruritus Relief Through Itch Scratch Modulation
Trial details
- Registry ID
- NCT03497975
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as NAL ER Tablets
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PRISM Study-Pruritus Relief Through Itch Scratch ModulationNCT03497975 | Trevi Therapeutics | Phase 2, Phase 3 | Completed | 2022-05-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |